PL3257511T3 - Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania - Google Patents
Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzaniaInfo
- Publication number
- PL3257511T3 PL3257511T3 PL15882014T PL15882014T PL3257511T3 PL 3257511 T3 PL3257511 T3 PL 3257511T3 PL 15882014 T PL15882014 T PL 15882014T PL 15882014 T PL15882014 T PL 15882014T PL 3257511 T3 PL3257511 T3 PL 3257511T3
- Authority
- PL
- Poland
- Prior art keywords
- orally disintegrating
- disintegrating tablet
- manufacturing same
- tablet
- orally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015024699 | 2015-02-10 | ||
| JP2015140608 | 2015-07-14 | ||
| PCT/JP2015/075749 WO2016129140A1 (ja) | 2015-02-10 | 2015-09-10 | 口腔内崩壊錠及びその製造方法 |
| EP15882014.2A EP3257511B1 (en) | 2015-02-10 | 2015-09-10 | Orally disintegrating tablet and method for manufacturing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3257511T3 true PL3257511T3 (pl) | 2019-03-29 |
Family
ID=56614591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15882014T PL3257511T3 (pl) | 2015-02-10 | 2015-09-10 | Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170304196A1 (pl) |
| EP (1) | EP3257511B1 (pl) |
| JP (2) | JP6371866B2 (pl) |
| DK (1) | DK3257511T3 (pl) |
| ES (1) | ES2700364T3 (pl) |
| PL (1) | PL3257511T3 (pl) |
| WO (1) | WO2016129140A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6946029B2 (ja) * | 2016-03-30 | 2021-10-06 | エスエス製薬株式会社 | 経口用医薬組成物 |
| EP3717550A2 (en) * | 2017-12-01 | 2020-10-07 | Cable Components Group LLC | Foamable compositions and methods for fabricating foamed articles |
| WO2019131891A1 (ja) * | 2017-12-28 | 2019-07-04 | 大日本住友製薬株式会社 | 苦味がマスキングされた薬物含有粒子及び該薬物含有粒子を含む製剤 |
| CN110013467B (zh) * | 2018-01-10 | 2021-09-17 | 上海汉都医药科技有限公司 | 一种固体微粒及其制备方法和含其的药物组合物 |
| US12116285B2 (en) * | 2018-10-05 | 2024-10-15 | Fuji Chemical Industries Co., Ltd. | Porous silica particle composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1452177A (en) * | 1920-04-02 | 1923-04-17 | Aragose Frank | Spark plug |
| JPS5176413A (ja) * | 1974-12-25 | 1976-07-02 | Toyo Jozo Kk | Hifukuzainoseizoho |
| JP2000119198A (ja) * | 1998-10-16 | 2000-04-25 | Eisai Co Ltd | 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤 |
| EP1452177A1 (en) * | 2003-02-27 | 2004-09-01 | Boehringer Ingelheim International GmbH | Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent |
| EP2040676A2 (en) * | 2006-07-06 | 2009-04-01 | Forest Laboratories, Inc. | Orally dissolving formulations of memantine |
| TWI441658B (zh) * | 2008-03-11 | 2014-06-21 | Takeda Pharmaceutical | 口腔崩解固體製劑 |
| JPWO2011062194A1 (ja) * | 2009-11-18 | 2013-04-04 | 武田薬品工業株式会社 | アミノピリジン誘導体 |
| JP5680898B2 (ja) * | 2010-08-10 | 2015-03-04 | 京都薬品工業株式会社 | 苦味を抑制した速崩壊錠 |
| JP2012056909A (ja) * | 2010-09-10 | 2012-03-22 | Fuji Chem Ind Co Ltd | 苦味薬物の苦味を低減した医薬組成物 |
| RU2503447C1 (ru) * | 2012-11-20 | 2014-01-10 | Максим Эдуардович Запольский | Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства |
-
2015
- 2015-09-10 EP EP15882014.2A patent/EP3257511B1/en not_active Not-in-force
- 2015-09-10 JP JP2016574620A patent/JP6371866B2/ja not_active Expired - Fee Related
- 2015-09-10 WO PCT/JP2015/075749 patent/WO2016129140A1/ja not_active Ceased
- 2015-09-10 DK DK15882014.2T patent/DK3257511T3/en active
- 2015-09-10 ES ES15882014T patent/ES2700364T3/es active Active
- 2015-09-10 PL PL15882014T patent/PL3257511T3/pl unknown
-
2017
- 2017-07-11 US US15/646,102 patent/US20170304196A1/en not_active Abandoned
-
2018
- 2018-07-06 JP JP2018129325A patent/JP6628840B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2700364T3 (es) | 2019-02-15 |
| JP6628840B2 (ja) | 2020-01-15 |
| EP3257511B1 (en) | 2018-10-24 |
| WO2016129140A1 (ja) | 2016-08-18 |
| JP6371866B2 (ja) | 2018-08-08 |
| EP3257511A4 (en) | 2018-01-24 |
| DK3257511T3 (en) | 2019-01-21 |
| EP3257511A1 (en) | 2017-12-20 |
| JP2018150384A (ja) | 2018-09-27 |
| JPWO2016129140A1 (ja) | 2017-06-29 |
| US20170304196A1 (en) | 2017-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201509751D0 (en) | Tablet case and method of manufacture | |
| EP3135394A4 (en) | Method for manufacturing hot press forming part and hot press forming part | |
| EP3219671A4 (en) | Aerogel and manufacturing method thereof | |
| IL254818A0 (en) | Ribociclib tablet | |
| IL262312A (en) | Disintegrating tablets for oral administration | |
| SG11201800591TA (en) | Tablet | |
| SG11201801027SA (en) | Apparatus and manufacturing method | |
| GB2591026B (en) | Improvements in tablet manufacture | |
| GB2560293B (en) | Biochip and method for manufacturing biochip | |
| PT3449912T (pt) | Comprimido de desintegração por via oral | |
| GB2555956B (en) | A cabinet and method for manufacturing a cabinet | |
| GB2557762B (en) | Thru-casing section mill | |
| PT3446684T (pt) | Comprimido orodispersível | |
| GB201501603D0 (en) | Method and product | |
| EP3270900A4 (en) | Carbohydrate tablet and method of fabrication | |
| PL3257511T3 (pl) | Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania | |
| SG11201810789WA (en) | Case and method for producing case | |
| TWI562884B (en) | Manufacturing method and manufacturing system | |
| ZA201704553B (en) | Recess plate and method for manufacturing the same | |
| EP3369548A4 (en) | Case and method for producing case | |
| PL3238712T3 (pl) | Tabletka ulegająca bardzo szybkiemu rozpadowi i sposób jej wytwarzania | |
| GB201511252D0 (en) | Tablet | |
| GB201506480D0 (en) | Manufacturing method and apparatus | |
| GB201518919D0 (en) | Tablet characterisation system and method | |
| IL235470A0 (en) | A hope and a method for building it |